Basics of Biosimilars

Thursday, February 28, 2019

9:30 a.m. – 9:40 a.m. Welcome and Introductions

Sarah Dash, MPH, president and chief executive officer, Alliance for Health Policy, @AllHealthPolicy

Scott White, MBA, company group chairman, North America Pharmaceuticals, Johnson & Johnson, @JanssenUS

9:40 a.m. – 10:20 a.m. Panelist Opening Remarks

Sameer V. Awsare, M.D., FACP, associate executive director, The Permanente Medical Group

Jeremy Sharp, senior vice president, Waxman Strategies

Adam J. Fein, Ph.D., chief executive officer, Drug Channels Institute, @DrugChannels

Anna Hyde, M.A., vice president, Advocacy and Access, Arthritis Foundation, @AnnaHydeAF

10:20 a.m. – 11:00 a.m. Question and Answer Session

Twitter
#AllHealthLive

Jun24

past webinar

COVID-19 Webinar Series Session 20 - Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic  and Where We Go From Here

Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders examined the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.

Learn More

Share